


Searching News Database: R7128
HSMN NewsFeed - 20 Apr 2009
Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
HSMN NewsFeed - 26 Nov 2007
Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
HSMN NewsFeed - 24 Oct 2007
R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
